The FDA is reviewing data to determine whether to authorize a fourth dose of mRNA COVID-19 vaccine in the fall, people familiar with the matter told The Wall Street Journal in a Feb. 19 report.
Read the full post on Becker's Hospital Review - Healthcare News
